Interacting genes in lithium prophylaxis: Preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients

Neuroscience Letters

Volumn 467, Issue 2, 2009, Pages 67-71

  Manchia, Mirko ^a   Squassina, Alessio ^a   Congiu, Donatella ^a   Chillotti, Caterina ^b   Ardau, Raffaella ^b   Severino, Giovanni ^a   Del Zompo, Maria ^a,b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b DEPARTMENT OF RADIOLOGY   (Italy)

Author keywords

Bipolar disorder; Gene gene interaction; Lithium prophylaxis; Logistic regression; Sardinia

Indexed keywords

CELL NUCLEUS RECEPTOR; DIACYLGLYCEROL KINASE; LITHIUM; PROTEIN DGKH; PROTEIN NR1D1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; EXPLORATORY RESEARCH; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

BIPOLAR DISORDER; DIACYLGLYCEROL KINASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; ITALY; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP D, MEMBER 1; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS;

EID: 70350751424     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.10.003     Document Type: Article

References (30)

1. Alda M., Grof P., Rouleau G.A., Turecki G., and Young L.T. Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 1038-1045
2. Arranz M.J., and de Leon J. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Mol. Psychiatry 12 (2007) 707-747
3. Balding D.J. A tutorial on statistical methods for population association studies. Nat. Rev. Genet. 7 (2006) 781-791
4. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
5. Baum A.E., Akula N., Cabanero M., Cardona I., Corona W., Klemens B., Schulze T.G., Cichon S., Rietschel M., Nöthen M.M., Georgi A., Schumacher J., Schwarz M., Abou Jamra R., Höfels S., Propping P., Satagopan J., Detera-Wadleigh S.D., Hardy J., and McMahon F.J. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol. Psychiatry 13 (2008) 197-207
6. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 25 (2003) 115-121
7. Endicott J., and Spitzer R.L. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry 35 (1978) 837-844
8. Garnham J., Munro A., Slaney C., Macdougall M., Passmore M., Duffy A., O'Donovan C., Teehan A., and Alda M. Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study. J. Affect. Disord. 104 (2007) 185-190
9. Gershon S., and Soares J.C. Current therapeutic profile of lithium. Arch. Gen. Psychiatry 54 (1997) 16-20
10. Greene C.S., Penrod N.M., Williams S.M., and Moore J.H. Failure to replicate a genetic association may provide important clues about genetic architecture. PLoS One 4 (2009) e5639
11. Grof P., Duffy A., Cavazzoni P., Grof E., Garnham J., MacDougall M., O'Donovan C., and Alda M. Is response to prophylactic lithium a familial trait?. J. Clin. Psychiatry 63 (2002) 942-947
12. Kato T. Molecular neurobiology of bipolar disorder: a disease of 'mood-stabilizing neurons'?. Trends Neurosci. 31 (2008) 495-503
13. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., and Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 51 (1994) 8-19
14. Kishi T., Kitajima T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Ozaki N., and Iwata N. Links association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population. Neurosci. Res. 62 (2008) 211-215
15. Kripke D.F., Nievergelt C.M., Joo E., Shekhtman T., and Kelsoe J.R. Circadian polymorphisms associated with affective disorders. J. Circadian Rhythms 7 (2009) 2
16. Merikangas K.R., Akiskal H.S., Angst J., Greenberg P.E., Hirschfeld R.M., Petukhova M., and Kessler R.C. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch. Gen. Psychiatry 64 (2000) 543-552
17. Ollila H.M., Soronen P., Silander K., Palo O.M., Kieseppä T., Kaunisto M.A., Lönnqvist J., Peltonen L., Partonen T., and Paunio T. Findings from bipolar disorder genome-wide association studies replicate in a Finnish bipolar family-cohort. Mol. Psychiatry 14 (2009) 351-353
18. Peltonen L., Palotie A., and Lange K. Use of population isolates for mapping complex traits. Nat. Rev. Genet. 1 (2000) 182-190
19. Post R.M., Roy-Byrne P.P., and Uhde T.W. Graphic representation of the life course of illness in patients with affective disorder. Am. J. Psychiatry 145 (1988) 844-848
20. Quiroz J.A., Gould T.D., and Manji H.K. Molecular effects of lithium. Mol. Interv. 4 (2004) 259-272
21. Severino G., Manchia M., Contu P., Squassina A., Lampus S., Ardau R., Chillotti C., and Del Zompo M. Association study in a Sardinian sample between bipolar disorder and the nuclear receptor REV-ERBalpha gene, a critical component of the circadian clock system. Bipolar Disord. 11 (2009) 215-220
22. Shi J., Wittke-Thompson J.K., Badner J.A., Hattori E., Potash J.B., Willour V.L., McMahon F.J., Gershon E.S., and Liu C. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 147B (2008) 1047-1055
23. Spitzer R.L., Endicott J., and Robins E. Research Diagnostic Criteria for a Selected Group of Functional Disorders. 3rd edn. (1977), New York State Psychiatric Institute, New York, NY
24. Squassina A., Manchia M., Congiu D., Severino G., Chillotti C., Ardau R., Piccardi M.P., and Del Zompo M. The Diacylglycerol Kinase eta (DGKH) gene and bipolar disorder: a replication study in a Sardinian sample. Mol. Psychiatry 14 (2009) 350-351
25. Tiwari A.K., Souza R.P., and Müller D.J. Pharmacogenetics of anxiolytic drugs. J. Neural Transm. 116 (2009) 667-677
26. Uher R., Huezo-Diaz P., Perroud N., Smith R., Rietschel M., Mors O., Hauser J., Maier W., Kozel D., Henigsberg N., Barreto M., Placentino A., Dernovsek M.Z., Schulze T.G., Kalember P., Zobel A., Czerski P.M., Larsen E.R., Souery D., Giovannini C., Gray J.M., Lewis C.M., Farmer A., Aitchison K.J., McGuffin P., and Craig I. Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J. 9 (2009) 225-233
27. van Blitterswijk W.J., and Houssa B. Properties and functions of diacylglycerol kinases. Cell Signal 12 (2000) 595-605
28. Wade M.J. Epistasis, complex traits, and mapping genes. Genetica 112-113 (2001) 59-69
29. W.T.C.C.C. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
30. Yin L., Wang J., Klein P.S., and Lazar M.A. Nuclear receptor Rev-erbα is a critical lithium-sensitive component of the circadian clock. Science 311 (2006) 1002-1005